FDA Issues EUA for Monoclonal Antibodies to Treat COVID-19 in High Risk Patients
The FDA issued an EUA for the investigational antibody cocktail casirivimab and imdevimab for the treatment of mild-to-moderate COVID-19 in high risk patients.
AstraZeneca/Oxford COVID-19 Vaccine Candidate Third to Show Promise
The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.
Thanksgiving 2020: COVID-19 Considerations for Patients
Prepare patients for a safe Thanksgiving with key CDC-based recommendations including alternative Thanksgiving activities, steps to take if exposed to COVID-19, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 23, 2020
US confirmed cases of COVID-19 have surpassed 12 million; global cases have reached 58 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 20, 2020
Global confirmed cases of COVID-19 have surpassed 57 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Obesity and COVID-19: Meet Patients Where They Are
Americans with obesity and overweight are at greater risk for more severe COVID-19. Clinicians can support them best by asking how they can help.
A COVID-19 Thanksgiving: CDC Tips to Give Patients for a Safe Holiday
Ensure your patients have a fun and safe COVID-19 Thanksgiving holiday with these quick CDC-based tips.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 19, 2020
Global confirmed cases of COVID-19 have surpassed 56 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
FDA Issues EUA for First Rapid At-home COVID-19 Diagnostic Test
For the first time, patients at suspected risk of COVID-19 can test themselves at home and see results within 30 minutes.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 18, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Once-weekly Semaglutide 2.0 mg Bests 1.0 mg Dose for A1c, Weight Reduction
Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.
Response to Dupilumab in Severe Asthma Predicted by Baseline FeNo
Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.
Increased Blood Eosinophil Counts, IgE Levels Linked to Higher Exacerbation Rates in Severe Asthma
Increased blood eosinophil counts and IgE levels are associated with higher exacerbation rates in patients with severe asthma, according to new research presented at ACAAI 2020.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 17, 2020
US confirmed cases of COVID-19 have surpassed 11 million; global cases have reached 55 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
6 Essential COVID-19 Codes to Remember
COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.
Asthma, COPD, & Asthma-COPD Overlap: A Quiz in Differential Diagnostics
Distinguishing asthma and COPD can at times be problematic and the asthma-COPD overlap picture is even less clear. Check your recall of GINA/GOLD guidelines on all 3.
Moderna COVID-19 Vaccine Candidate Achieves 94.5% Efficacy in Phase 3 Trial
Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.
Omega-3s, Vitamin D Fail to Prevent Incident Atrial Fibrillation
AHA 2020: Daily supplementation with 2000 IU of vitamin D3/day and/or 840 mg omega-3 fatty acids/day did not reduce or increase risk of incident atrial fibrillation.
How to Optimize Telemedicine for Older Adults, During COVID-19 and Beyond
Telemedicine use has increased significantly since COVID-19 began and while not new to all patients and providers, can pose unique challenges to care for older adults.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 13, 2020